In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| 10-K | 10-K | 10-K | S-1/A |
Total revenues [+] | 0.2 | 20.4 | 0.0 | 3.1 |
Royalties | | | | 3.1 |
Revenue growth | -98.9% | | -100.0% | |
Cost of goods sold | 0.5 | 0.0 | 0.0 | 15.8 |
Gross profit | -0.3 | 20.4 | 0.0 | -12.8 |
Gross margin | -114.6% | 100.0% | | -413.7% |
Selling, general and administrative [+] | 70.4 | 92.7 | 80.7 | 5.1 |
General and administrative | 70.4 | 92.7 | 80.7 | 5.1 |
Research and development | 74.3 | 48.0 | 11.4 | |
Equity in earnings | -16.0 | -58.6 | -76.5 | |
Other operating expenses | -0.1 | 15.5 | 12.0 | |
EBITDA [+] | -160.6 | -194.3 | -180.6 | -17.8 |
EBITDA growth | -17.3% | 7.6% | 912.5% | |
EBITDA margin | -68937.8% | -953.6% | | -578.5% |
Depreciation and amortization | 0.2 | 0.0 | 0.0 | 0.0 |
EBIT [+] | -160.8 | -194.4 | -180.7 | -17.8 |
EBIT growth | -17.3% | 7.6% | 912.3% | |
EBIT margin | -69009.9% | -953.9% | | -578.7% |
Interest income | 0.5 | 0.2 | 0.1 | 0.0 |
Interest income | 0.5 | 0.2 | 0.1 | 0.0 |
Other income (expense), net [+] | 25.1 | 57.6 | 78.8 | 0.4 |
Gain (loss) on sale of assets | | 16.9 | | |
Unrealized gain/loss on derivatives | | 0.0 | 0.2 | |
Gain (loss) on foreign currency transactions | 6.9 | 8.5 | -0.2 | |
Change in fair value of warrants | | 0.0 | 0.2 | |
Change in value of contingent liability | 1.5 | 0.2 | -1.1 | |
Other | -1.4 | -0.3 | 0.4 | -0.3 |
Pre-tax income | -135.2 | -136.6 | -101.8 | -17.5 |
Income taxes | -6.2 | -4.0 | -0.3 | 0.0 |
Tax rate | 4.6% | 2.9% | 0.3% | 0.0% |
Minority interest | -5.0 | -6.4 | -8.8 | |
Net income | -152.4 | -167.8 | -169.8 | -24.4 |
Net margin | -65401.3% | -823.6% | | -790.7% |
|
Basic EPS [+] | ($0.98) | ($1.21) | ($1.83) | |
Growth | -19.4% | -33.5% | | |
Diluted EPS [+] | ($0.98) | ($1.21) | ($1.83) | |
Growth | -19.4% | -33.5% | | |
|
Shares outstanding (basic) [+] | 155.7 | 138.3 | 93.0 | |
Growth | 12.6% | 48.6% | | |
Shares outstanding (diluted) [+] | 155.7 | 138.3 | 93.0 | |
Growth | 12.6% | 48.6% | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |